You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
| Chapter title |
Advances and Challenges of CAR T Cells in Clinical Trials
|
|---|---|
| Chapter number | 3 |
| Book title |
Current Immunotherapeutic Strategies in Cancer
|
| Published by |
Springer, Cham, September 2019
|
| DOI | 10.1007/978-3-030-23765-3_3 |
| Pubmed ID | |
| Book ISBNs |
978-3-03-023764-6, 978-3-03-023765-3
|
| Authors |
Astrid Holzinger, Hinrich Abken, Holzinger, Astrid, Abken, Hinrich |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 3 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 24 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 5 | 21% |
| Student > Doctoral Student | 3 | 13% |
| Student > Postgraduate | 2 | 8% |
| Researcher | 2 | 8% |
| Student > Ph. D. Student | 1 | 4% |
| Other | 1 | 4% |
| Unknown | 10 | 42% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 5 | 21% |
| Biochemistry, Genetics and Molecular Biology | 2 | 8% |
| Agricultural and Biological Sciences | 2 | 8% |
| Nursing and Health Professions | 2 | 8% |
| Chemical Engineering | 1 | 4% |
| Other | 2 | 8% |
| Unknown | 10 | 42% |